Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Shareprice 35% below pp price

<< Previous

Bullboard Posts

Next >>

Comment by biorunon Mar 27, 2024 2:36pm

105 Views

Post# 35956156

RE:RE:RE:Shareprice 35% below pp price

Some smaller hands may have in fact done this, but certainly has not had a profound impact.

I would say the lower share price is helpful if one wants to take a reasonable risk and double one's money. There is fundamentally nothing different between when we trading at 13-14 cents vs now.

Seen it so many times before play out. Buy low, sell high, that's how money is made on penny stocks.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec